arrow
H

H. James Wedner

Washington University School of Medicine
H指数:35
被引数:4,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency

一项多中心临床研究,旨在评估免疫球蛋白20%皮下注射制剂每周/每两周给药方案在治疗经治患者中的药代动力学、有效性和安全性,以及负荷剂量/每周维持剂量给药方案在原发性免疫缺陷治疗初治患者中的疗效。

2025-11-120
OAAI
Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups: real-world evidence

Lanadelumab对遗传性血管性水肿控制及生活质量的影响:按疾病活动度亚组分析的真实世界证据

2025-08-050
OAAI
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis

多尼达罗森治疗既往长期预防治疗的患者中的遗传性血管性水肿

2025-07-170
PREAI
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
2024-07-0410
PRE
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)

贝那利珠单抗治疗儿童严重嗜酸性粒细胞性哮喘的药代动力学和长期安全性 (TATE研究)

2024-03-1612
OA
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial
2024-03-014
OAAI
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity
2024-01-042
OA
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
2022-12-227
OAAI
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
2022-06-0112
OAAI
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
2021-07-01100
OAAI
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)
2021-06-0137
OAAI
Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit
2019-07-0148
PREAI
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks A Randomized Clinical Trial
2018-11-27203
OAAI
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2study
2018-06-1729
OAAI
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
2017-02-23147
OAAI